MiR-130b can target at down regulating the level of PTEN, following by an attenuation of the inhibition in PI3K/AKT/GSK-3β/β-Catenin pathway, and ultimately resulting in the malignant metastasis of NSCLC [73] (Fig. 4). Here, AKT1 is linked to non-small cell lung carcinoma.